ruboxistaurin proposed brand name arxxant investigational drug diabetic retinopathy investigated eli lilly company member bisindolylmaleimide family february lilly submitted new drug application ruboxistaurin august lilly received approvable letter us fda request additional clinical trial would take years lilly made request approval ruboxistaurin approved fda medical ruboxistaurin inhibitor protein kinase drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikiruboxistaurin